Clinical trial
Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial
NCT02623426 is registered in ClinicalTrials.gov with JHSPH Center for Clinical Trials as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial
- Lead sponsor
- JHSPH Center for Clinical Trials
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 9, 2017
- Completion date
- February 2, 2022
- Enrollment
- 194 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.